SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?


To: DanZ who wrote (4732)10/19/2003 3:26:54 PM
From: StockDung  Respond to of 5582
 
Donald J. Gunn JR's CRD# 1442917 Alleged Scheme

Floyd D. Schneider's complaint will allege that NASDAQ broker Donald J. Gunn Jr of GunnAllen Financial organized a "cartel" to purchase a huge percentage of the Gum Tech/ Matrixx of over 4 million shares. Gunn then allegedly arranged for a number of other brokers in the firm to conspire to control almost the entire float of GUMM/MTXX stock.

At the time of Donald J. Gunn Jr's alleged manipulation the trading float of GUMM was 5.6 million shares. Using a conservative 4 million shares this meant that 1 broker controlled an amazing 71.42% of the tradable float. Aided buy his stock broker cohorts at GunnAllen the firms clients where able to control the remaining 1.6 million share float of the GunnAllen "House Stock".

Schnieder claims subsequently to have learned that Donald J. Gunn Jr. and his associates had continued to buy the stock to manipulate a short squeeze. Through an undisclosed lock up agreement the scheme was aided by Donald J. Gunn's "catrel" not to sell the stock.

Donald J. Gunn Jr further manipulated the stock of GUMM?MTXX by making sure that the stock was not to be loaned out and over 4 million shares of his clients accounts where placed in cash accounts to further his manipulative scheme.

Donald J. Gunn Jr. Further more started telling message board posters and investors of gumm of this non disclosed conspiracy. Then Donald J. Gunn Jr scheme was aided further by him telling people interested in trading the stock that this "Cartel" was not going to sell any of their shares of GUMM stock until the company was "Bought out."

INTERNET STOCK TOUT DAN ZIMMERMAN AND GUMM ANALYST CONFIRMS THE ALEDGED SCHEME

In Dan Zimmermann's 1999 post Dan confirms what has always not been known. Dan states "It is my understanding that GunnAllen customers own between 60 and 65 percent of GUMM".
60% to 65% of GUMM stock at the time represeted almost the entire float of Gum Tech at the time of the manipulation.

Like all good schemes Donald would find out that when you tell such secrets "NEVER POST IT ON AN INTERNET WEB CHAT SITE." Unfortunatly that is exactly what had occured.

Donald would soon find out that the perfect sheme would soon become a nightmare.

------------------------------------------

"Jay Gunn 1-800-713-4046 his long term clients own over 4 million shares and they have no intention to sell until the company gets bought out.(Talk to him about the buyout price of GUMM)"

To:Bo Didley who wrote (7)
From: J. Gunn,Jr Friday, Jan 22, 1999 1:47 PM
View Replies (1) | Respond to of 130

Any information credited to me by bo didley or any other person or message board is inaccurate and unauthorized. I have made no previous postings regarding any stock and I will make no future postings.

J. Gunn

===============================

BO DOES KNOW DIDDLY

"GunnAllen Financial
Jay Gunn 1-800-713-4046
his long term clients own over 4 million shares
and they have no intention to sell until the company gets bought out.
(Talk to him about the buyout price of GUMM)

bo"


To:Howard D. Epstein, M.D. who wrote (6)
From: Bo Didley Thursday, Jan 21, 1999 1:42 PM
View Replies (3) | Respond to of 130

GUMM --- STRONG BUY RATING -- $24
We are reiterating our Buy rating on GumTech International with a FY 1999 price objective of $24. This price objective is based on sales estimates of $23.5 million and $56.1 million for FY1999 and FY2000, respectively. Based on our sales estimates, GumTech could post per share earnings of $.47 for FY1999 and $1.64 for FY2000.

We continue to de-emphasize Q3 and Q4 operating results, however, based on the infancy of new product lines including Breath Asure and Ranir, and to some extent the dental gum market, while maintaining a bullish longer-term outlook. Shipments of these new gums into distribution channels have commenced, and primary indications point to strong demand for both products.

We believe that Breath Asure could capture 8.9% of the $390 million dental gum market by FY2000, while Ranir could capture as much as 7.1%. During this period we are confident that at least one, if not several, branded oral care companies will be participating in the market for dental gums.

Since the FDA apparently views plaque as a disease, and any products claiming to reduce plaque are considered to be drugs, we view GumTech's sole position as a U.S. gum manufacturing facility that currently follows the Food and Drug Administration's "drug Good Manufacturing Practices" as a clear competitive advantage in the dental gum market.

Although we decline to cite a definitive time frame, GumTech should commence domestic and international distribution of nicotine (drug) containing gums, as well as further penetrate the market for diet aiding gums, by FY 2000.

GunnAllen Financial
Jay Gunn 1-800-713-4046
his long term clients own over 4 million shares
and they have no intention to sell until the company gets bought out.
(Talk to him about the buyout price of GUMM)

bo


=========================================

Subject 25049

SI: StockTalk: Miscellaneous (Biotech/Medical) : # [GUMM] Gum Tech ------ drugs in chewing Gum

Replies: 130 Member Bookmarks: 12

Remove Bookmark | Related Subjects | Hide original post

Started By: Street Walker
Date: Jan 19, 1999 2:01 PM
Gum Tech International (Nasdaq: GUMM)

The Company develops and manufactures specialty chewing gum products for branded and private label customers, as well as products marketed under the Gum Tech brand. The products contain vitamins, herbals and/or active drug ingredients. Gum Tech currently targets four market segments: oral care, smoking cessation, dietary supplement, and over-the-counter (OTC) drug.

5.6 million Float
But it will behave like it has 1.6 million float because
~4 million of the float is held by long term holders who
have extremely high price targets in the long term and have no
plans to sell. The long term share holders have removed their shares from being able to be shorted.

Each time the effective float of 1.6m is recycled the support level rises. As the effective float is recycled there will be shareholders who will simply not sell. Which means the effective float decreases while demand increases.

Regards,
S.W.

=============================

To:Mad2 who wrote (128)
From: Dan Zimmermann Saturday, Mar 6, 1999 5:13 PM
View Replies (1) | Respond to of 130

Mad2,
My apologies...I meant to ask my question about your short position through Olde, not Datek. So here it goes again.

Did Olde tell you that you had to cover your short position within 10 days after the settlement date? Again, if you consider this too personal, no need to reply. I'm not trying to get nosy into your business; I'm just trying to find out how the rule is applied in practice. Did you know that you had to close out your short within 10 days or did the rule not apply to you? I'm just trying to understand the rule.

It is my understanding that GunnAllen customers own between 60 and 65 percent of GUMM. That is substantial and you can bet that I keep my eye on GNLN on Level II. They have yet to be on the inside offer and are almost always on the inside bid or very close to it. Their offer is usually way away from the market, sometimes up to 1 point from the inside offer. This tells me that GunnAllen continues to buy, either the market maker for his/her own account or their customers. What you can't see on Level II is if GNLN sells at the bid. You can only see their offers (limit sell orders).

Their market maker's actions are consistent with GunnAllen's rating on the stock, which is buy. They have owned GUMM for a while and I seriously doubt if they will change their rating any time soon. GunnAllen believes in the future prospects of GumTech and several GunnAllen employees own the stock. Of course, something could happen to change their opinion, but I don't see that happening in the short term because the company is growing in accordance with their projections. With the additional revenue from Zicam, GumTech may even exceed their current projections.

What more do you want to know about Geltech LLC? Maybe I can answer your questions?



To: DanZ who wrote (4732)10/19/2003 5:46:21 PM
From: StockDung  Respond to of 5582
 
"ZICAM Cuts Duration of Common Cold From 10 - 14 Days to 1.5 Days"

Wednesday January 27, 9:05 am Eastern Time
Company Press Release
SOURCE: Gel Tech, Inc.
ZICAM Cuts Duration of Common Cold From 10 - 14 Days to 1.5 Days
New technology leads to breakthrough treatment
WOODLAND HILLS, Calif., Jan. 27 /PRNewswire/ -- Five percent of the American population is waging war against the common cold at this very moment. The average adult, in fact, will catch two to five colds in 1999. Finally, there's a highly effective treatment for the common cold. In initial double- blind research, ZICAM(TM) cold remedy not only relieved and reduced the severity of cold symptoms, but also reduced the duration of the common cold from 10 - 14 days to an average of 1.5 days.
ZICAM nasal gel brings welcome relief to those who suffer from the more than one billion common colds that occur in the United States each year. More than 110 million of these colds are disabling, causing approximately 300 million days of restricted activity, 60 million lost days of school and 50 million lost days of work each year.

History of Cold Research

Medical science has failed to find a cure for the common cold mainly because colds can be caused by more than 200 different viruses. Therefore, the standard medical paradigm of treating infectious ailments by vaccine has not been a viable option.

It is known, however, that the main portal of entry of the cold virus into the body is the cell lining of the nasal cavity. In the 1980s, it was discovered that the majority of viruses responsible for the common cold used a common entry point into the human body: the nasal cell ICAM-1 receptor. It was evident that if scientists found a way to block the attachment of cold viruses to these receptors, a cure of the common cold would be at hand.

Making Cold History: How ZICAM Works

ZICAM works in the nasal passages, fighting the cold where it starts. Once ZICAM is applied to the nasal cavity, the active ingredients bind to the cold virus and keep the virus from attaching to the ICAM-1 receptors. Once this occurs, there is a break in the cascade of infection and the cold quickly dissipates.

ZICAM's unique gel matrix maintains suspension of Zinullose(TM) ZICAM's active ingredient, in the nasal membrane. This provides constant release of Gel Tech, Inc.'s unique patent-pending ionic emulsification formula, which blocks the cold virus entry for many hours after application.

''ZICAM is most effective when sprayed into the nose at the onset of the infection, reducing symptoms and the duration of the common cold,'' said Dr. Charles B. Hensley, chief of research and scientific affairs and executive vice president for Gel Tech.

Research

Initial clinical research shows that ZICAM is highly effective as a treatment for the common cold. When taken at the onset, it reduced the duration of the cold from 10 - 14 days to an average of 1.5 days. Currently, researchers at a major university are preparing to conduct a large-scale clinical trial to test the effectiveness of ZICAM as a preventative treatment. Preliminary results suggest that when used once a day during the cold season, ZICAM will effectively protect against the common cold.

ZICAM is developed by and manufactured for Gel Tech, Inc. (a joint venture by BIODELIVERY Technologies, Inc., a privately-held biotechnology company, and GumTech International, Inc., a publicly-held company located in Phoenix, Ariz.). Gel Tech's mission is to develop and provide innovative products that change consumers' expectations for the over-the-counter products they need and use.

For more information on ZICAM, visit Gel Tech's web site at zicam.com

SOURCE: Gel Tech, Inc.



To: DanZ who wrote (4732)10/19/2003 6:12:16 PM
From: StockDung  Respond to of 5582
 
ETIOLOGY OF THE COMMON COLD By R. Steven Davidson, Ph.D. and Charles B. Hensley, Ph.D.

Acute respiratory illness accounts for over one-half of all acute disabling conditions annually, according to national health survey data. In the United States alone, the common cold, which is a viral infection of the superficial columnar cells of the nasal turbinate epithelium, is the most common of identifiable acute respiratory disorders and accounts for about 20 percent of all conditions and ailments and about 40 percent of all respiratory conditions. This includes 110 million disabling colds per year, causing about 300 million days of restricted activity, about 60 million lost days of school, and about 50 million lost days of work. When considering minor, nondisabling respiratory illnesses, common cold represent a higher proportion of respiratory diseases.

Colds are estimated to occur at rates of two to five per person per year. About five percent of the population has a cold at any given time. Over one billion common colds occur in the United States each year. Financial considerations of the common cold are staggering. Over five billion is spent each year on colds in the United States. About $3 billion is spent on professional consultations with about $1.5 billion on remedies and about $1 billion on analgesics.

Over 200 types of viruses induce common colds, with over 113 types of human rhinoviruses causing the majority. Nasal drainage and nasal congestion are primary symptoms of common colds. Malaise, headache, fever, muscle pain, sore throat, scratchy throat, cough and hoarseness are frequently occurring secondary symptoms.

The nose is the body's first line of defense against airborne viruses. The temperature and moisture of the inner nose tend to inhibit growth of some viruses. The nasal turbinates, with their flaplike shape and copious blood supply, assist in warming and moistening the inspired air. The interior of the nose is lined with goblet cells that excrete sticky mucus. The cells lining the respiratory tract also secrete immunoglobulin A (lgA) helping to prevent infections by combining with the surfaces of viruses and bacteria to change their shape into one not allowing attachment. Recently, intercellular adhesion molecule 1 (ICAM-1) has been identified as the molecule that attaches rhinoviruses to cells.

During a cold, viruses have managed to penetrate nasal mucus and invade nasal tissues. Within a few hours, viruses bind to ICAM-1 sites on the surface of the nasal cells and subsequently penetrate them. As cells become infected, they release chemicals initiating several responses from the body's immune system, including responses from immune cells of the nasal mucosa.

Within an hour, prostaglandins are released producing inflammation and attracting infection-fighting white blood cells called neutrophils. These cells attempt to attack an invading virus without damaging infected cells. Neutrophil activity increases inflammation and the infected area becomes swollen and red. Onset of a common cold is thus signaled with symptoms such as sore throat, itchy eyes, a headache, or generalized ill feeling. Tissues and capillaries dilate, while plasma, additional neutrophils and other white blood cells flood the area. Symptoms include increased mucus production, raised temperature, runny nose, sneezing and coughing.

Colds are caused by more than two hundred different viruses that enter the body by binding to receptors on cells lining the nasal cavity. Once the cold virus has entered the nasal cavity, they infect and re-infect the body for several days, eventually overwhelming the body's immune system. Statistics have shown that on an average, the cold lasts about 12 days. In the 1980s it was discovered that the majority of viruses responsible for the common cold used a common entry point into the human body, the nasal cell ICAM-1 receptor. Colds actually start in the nasal cavities. During a cold, viruses manage to penetrate nasal mucus and invade nasal tissues. Viruses bind to ICAM-1 binding sites on the surface of the nasal cells, enter the cells and within a few hours, seize control of cell genetics and force cells to make thousands of copies of invading viruses. The newly formed rhinoviruses then not only enter the systemic circulation, but also are expelled back into the nasal cavity, thereby infecting neighboring nasal epithelial cells. This process of infection and re-infection continues resulting in an extended illness. The key point is that the rhinoviral entry mediated by binding to the ICAM-1 site of the nasal epithelium is a critical first step in the infection process.

Researchers have been working tirelessly to find a drug that would stop or inhibit that entry point. It is hypothesized that if a drug could bind to the viral ICAM binding site, you would eliminate the virus from ever infecting the body. The drug would work like a lock and key mechanism preventing the virus from attaching to the nasal cells.

Conventional drugs have only succeeded in limiting the symptoms of the cold. Look for a new paradigm in the fight against the common cold. New therapeutics are emerging, ones that help shorten the duration of the common cold as well as influence intercellular adhesion molecules.



To: DanZ who wrote (4732)10/19/2003 6:28:14 PM
From: StockDung  Respond to of 5582
 
DAVIDSONS Ph.D lol->Remit Cashiers Check in the Amount of $100.00 (USD) Credit for Work Experience, YOUR CHANCE
MBA-Study / PhD-Study Give your Career a power Surge....... * Application (life and work experience Diploma-Programmes)

The tuition fees for the study programmes are as follows: (*USD=US-DOLLAR)Bachelor Degree 2.500,-- USD
Master Degree 3.500,-- USD
Ph.D. (doctoral degree) 5.000,-- USD

Please send us your curriculum vitae (CV) and we can look wether it is possible to award you diplomas from our university. Some diplomas based on life experience an work experience.

"Dr. Davidson received his MBA in International Finance and Ph.D. in Biopharmaceutical Project Management from the American University of Asturias, Spain" zengen.com

R. Steven Davidson, Ph.D., MBA
President, Chief Executive Officer and Director

Dr. Davidson has been the Company's President and Chief Executive Officer since January 2002 and a director since April 2002. Dr. Davidson has over eight years of experience in the biopharmaceutical industry. From September 1998 to December 2001, Dr. Davidson was the chief executive officer and a director of Gel Tech, LLC. At Gel Tech, Dr. Davidson raised capital for the market launch and distribution of the Zicam™ cold remedy. He led the marketing team that took Zicam™ from an unknown entity to one of the top medications in its class. He also implemented and launched line extensions to strengthen brand name and increase company value. During this period, Dr. Davidson was also the managing director of Biodelivery Technologies, Inc. From October 1994 to August 1998, Dr. Davidson was the chief executive officer of Biotem Cytotechnologies, Inc., a biopharmaceutical research and development company. Dr. Davidson received his MBA in International Finance and Ph.D. in Biopharmaceutical Project Management from the American University of Asturias, Spain and performed post graduate studies at Villanova University.

Return to Executive Officers Menu

Zengen, Inc - R. Steven Davidson, Ph.D., MBA

===========================================
"who the past year were dismissed of their position after the scandal of the fictitious American University of Asturias (AUNA),
ASTURIAS, 23/03/2002 "
================================================
ECONOMIA
The ex- manager of Perlora dismissed after the scandal of the Chinese, new stop position of the IFR

The Principality names person in charge of the centers of companies public to the Costal Fernandez, affected by the controversy of the American University

Oviedo, F. B.

The ex- manager of the Residential City of Perlora, Jose Ramon the Costal Fernandez, who the past year were dismissed of their position after the scandal of the fictitious American University of Asturias (AUNA), has been named responsible for the Association of Centers of Companies Public of the Principality of Asturias (Aceppa), a dependent organism of the Institute of Fomento Regional (IFR).

Bags position has become of an association that is presided over by the chief of a main directorate of the IFR, Carlos Garci'a Morilla, and that was constituted in June of 2000 as it leaves from the performances anticipated in the territorial pact by the use in the mining regions.

Aceppa is integrated by the Municipal Center of Companies of Gijón, the Scientific and Technological Park of Gijón, the Center of Companies of the Nalón, the Curtidora de Avilés, the European Center of Studies and Innovation, the Center of Companies of the Volume, the Technological City Valnalón and the Center of Enterprise Promotion of Tineo.

The association must like aims support to these centers in its functions of advising to companies, to promote for them services and infrastructures and programs actions that contribute to the development of the societies located in the centers.

The appointment of Bags takes place after the advisor of Industry, Jesus Urrutia, dismissed it like manager of the Residential City of Perlora after the controversy arisen when knowing itself that this center had been rented by the then chief of a main directorate of Commerce and Tourism, Tomás Flowers, to the denominated American University of Asturias (AUNA).

The supposed educational activity of the AUNA attracted Chinese citizens who counted on visas to remain three months in Spain and which later they occurred by disappear. Tomás Flowers also was dismissed of its position after a fraud that got to cause that Perlora appeared in Internet like the AUNA seat.

=============================================

From: Tiara (tiara@hotmail.com)
Subject: Re: American University of Suriname
View: Complete Thread (12 articles)
Original Format
Newsgroups: alt.education.distance
Date: 2000/04/17

And - I guess - The American University of Asturias, in Europe (Spain).
asturnet.es
T.

John Bear wrote:

> I guess you can't keep a bad man down. Or two in this instance. Comes
> now the new and fake American University of Suriname, ostensibly in
> South America, with its German-based web site in English,
> mba-study.de
>
> The two names on the website and the pictured diploma are Dennis Muhilly
> (associated with the fake Eire International University, the curious
> APICS accrediting agency, La Jolla University, and other wonders), and
> John Tulip (who has been associated with Mellen University).
>
> If there is a news group reader in Germany, it would be lovely to learn
> what is to be found at:
> Hinterm Graben 4-10 - D-35708 Haiger/Germany Phone: 0049-2773-94270
> Fax.:0049-2773-942720
>
> John Bear
> degree.net
=================================

web.archive.org

www.mba-study.de

YOUR CHANCE
MBA-Study / PhD-Study
Give your Career a power Surge.......

with an online Master`s and Ph.D. from A.I.U. American International University
(Formerly American University of Suriname)
A full state recognized ministerial chartered University

Letter of the President

Information of the American University

MBA-Programmes (Distance Learning)

Normal-Study-Programmes

Credit for Work Experience

Application (life and work experience Diploma-Programmes)

Evaluation in Germany

Downloads for Online Study (Members Only)

[ Letter of the pres. ] [ Application Form ] [ Application ] [ MBA ] [ Evaluation in USA ] [ Normal Study ]

Visitor No. at

This Site is still under Construction

web.archive.org
www.mba-study.de YOUR CHANCE
MBA-Study / PhD-Study
Give your Career a power Surge.......

American International University
A STATE RECOGNIZED MINISTERIAL CHARTERED UNIVERSITY

Has been granted a State Recognized Charter by:

The Ministry of Education
and
The Ministry of Trade & IndustryUniversity Programs:
Courses are offered at the Associate, Bachelor,Master, Doctoral, Post-Graduate and Specialization (Certificate) Levels
Courses of StudyAgriculture Arts and Scienes
Biology Business
Chemistry Computer Science
Education English as a Second Language
Engineering Fine Arts
Human Behavior Humanities
Law Ophthalmic Science
Optometry Physics
Psychology Medicine
Medical Sciences Natural Sciences
Pharmacy Social Work
Sociology Statistics
Frafic & Safty Managment Managment

Overview
The Country of Suriname is located on the Northeast coast of South America with Guyana to the West, French Guyana to the East and Brazil to the South. In terms of size, it is one-tenth larger than the State of Michigan (USA).Suriname was a former Dutch Colony and was returned to Democratic rule in 1987. The Capital City Is Paramaribo.English is widely spoken throughout the country. Education is important as illustrated by the 95% literacy rate.Surinames`s major trading partners are: The United States, Germany, England, Brazil , and Japan.Program Design Traditional Classes
Distance Learning Program
Comprehensivly Designed Intensive Learning Modules
Internationally Distinguished Faculity
All Programs are in English

Application for Admission Complete Application
Request Official Transcripts
Remit Cashiers Check in the Amount of $100.00 (USD)
Recognition of the University:
The American International University was granted a State Recognized Charter with fill approval of the curriculum by the Ministry of Education.It should be noted that a state recognized degree is equal to and can be evaluated by recognized evaluation agencies in the United States as an equivalent degree an therefore equal to an American granted Regionally Accredited Degree. (n.b. Accredited Status is US Terminology)

Created by Prof. Dr. K.Muhilly
(President)
15.12.1999

www.mba-study.de YOUR CHANCE
MBA-Study / PhD-Study
Give your Career a power Surge.......

American International University
(Formerly American University of Suriname)
February 1999Letter by the President
Bachelor/Master or Doctoral DegreeDear Madam,
Dear Sir,We thank you for your interest in our University Programmes and we like to inform you as follows: In the year 1997 the Colorado University of International Business and Technology was integrated in the university structures of the American International University.The International University of Business and Technology (IUBT/USA) was also integrated into the A.I.U. . The American International University is a full state recogniced and legalized University by the responsible ministry.The American International University has study centres in South-Carolina (USA), in Germany, in Russia,in Czech Republic,in Bulgaria, in Afrika and in other European States, and in South America.If you decide to get a diploma from the A.I.U. (American International University) you receive a diploma from a state recogniced university, so that this is for you a big advantage. The central study centre is in Paramarito (Suriname) , in Greenville (South Carolina / USA) and in Denver (USA).Please send us your curriculum vitae (CV) and we can look wether it is possible to award you diplomas from our university. Some diplomas based on life experience an work experience.
The tuition fees for the study programmes are as follows: (*USD=US-DOLLAR)Bachelor Degree 2.500,-- USD
Master Degree 3.500,-- USD
Ph.D. (doctoral degree) 5.000,-- USD

It is also possible to get the positon of a "Honorary Professor (Prof.)" . Enclosed you receive a list about the different special fileds in which the A.I.U. is able to award the diplomas.The diplomas can be awarded because of your professional experience and your already presented curriculum vitae and the certificates. lf you are interesting in a diploma of the A.I.U. ( study centre in South-Carolina/USA) and we ask you to complete the enclosed application form and to send it back to us by fax. Please send your documents to our European representation in Germany, who is available under the following address and fax-no.:

American International University
c/o TMT AG
Technology-Management-Transfer
Hinterm Graben 4 - 10
D-35708 Haiger/Germany
Fax-No.: +49-2773-9427-20
e-mail:TMT-AG@t-online.de

lf you have any questions don't hesitate to contact us.

Yours faithfully

A.I.U./CUIBT/IUBT
sgn. Secretary of the President Prof. Dr.Dr. Muhilly

We also have cooperation contracts and contact to State Universities in: United Kingdom Africa
USA and South America Austria
Poland Hungary
Czech Republic Germany
Russia and other state and
Bulgaria private universities
Romania
France
Italy

Created by Prof. Dr. K.Muhilly



To: DanZ who wrote (4732)10/19/2003 6:46:02 PM
From: StockDung  Respond to of 5582
 
Dr. Denis K. Muhilly

Association for Promotion of International Cultural and Scientific Exchange (APICS) With offices in Canada and Switzerland, this organization's secretary general is Dr. Denis K. Muhilly, who hasn't always been happy with things we've said about him in the past. All we know about this organization right now is that they've approached quite a few schools to discuss European accreditation. Also known by the German name Akademie fuer Internationale Kultur und Wissenschaftsfoerderung. degree.net



To: DanZ who wrote (4732)10/19/2003 7:08:33 PM
From: StockDung  Read Replies (1) | Respond to of 5582
 
BTW, Davidsons school was run by the dubious John Tulip lol and Dr Dennis Muhilly. Davidsons school a/k/a fake American University of Suriname, ostensibly
in South America, with its German-based web site in English, mba-study.de. The
two names on the website and the pictured diploma are Dennis Muhilly (associated with the
fake Eire International University, the curious APICS accrediting agency, La Jolla University, and other wonders),
and John Tulip (who has been associated with Mellen University)
===============================================

groups.google.com
May 13th/2000.
Here is a partial email message to myself from John Bear on the subject
of "APICS", written and
mailed on May 13th 2000: (Bear writes as follows): I can think of
nothing positive to say about APICS,
Earon. The long-time involvement of Denis Muhilly, who has been
associated with 3 or 4 places that
I have no problem calling degree mills (e.g., Eire International
University) does not help. Nor does the
fact that when I contacted the only findable American who was listed as
one of their board people
(a professor at Stanford), he was outraged to learn that they were using
his name.
I have conveyed such information (more than four months ago) to Les
Carr, regarding Senior U,
and I am troubled by that connection. (end of comments from John Bear).

John states that Dennis Muhilly, one of the principals behind APICS is
now also operating the
American University of Suriname, another fake school. On 4/16/2000 John
Bear provided other
information on Dennis Muhilly, on alt.distance.ed, a Usenet newsgroup
that focuses largely on
scams in higher education and degree/diploma mills:
(Bear writes as follows): I guess you can't keep a bad man down. Or two
in this instance.
Comes now the new and fake American University of Suriname, ostensibly
in South America,
with its German-based web site in English, mba-study.de. The
two names on the
website and the pictured diploma are Dennis Muhilly (associated with the
fake Eire International
University, the curious APICS accrediting agency, La Jolla University,
and other wonders),
and John Tulip (who has been associated with Mellen University) (finish
of comments from John Bear).
Bear has written on the totally illegal and fraudulent Mellon University
for many years, going back
into the 1980's.

And finally, on 05/13/2000, Bear comments on alt.education.distance,
about how bogus accreditors
"accredit" well-known schools without their knowledge. According to Bear
APICS is one of the
"accreditors" that engage in this practice. Bear was replying to
comments about how WAUC
(another bogus accreditor) claimed to have accredited the totally
legitimate and private Universidad
de las Am ricas in Costa Rica.

(Bear writes as follows): I'm not personally familiar with this school,
but it sounds like the classic
scam that other fraudulent accreditors such as APICS and the bogus
agency that Columbia State
set up to accredit itself. The accreditor (in this case, WAUC) bestows
unwanted and unrequested
"full accreditation" on a couple of legitimate schools, often without
even letting them know that
they've been granted the dubious honor. Then, the accreditor can point
to the one or two legit schools
in their roster and say "See!! We accredit legitimate programs!!". Snell
at Monticello (a fraud artist recently
convicted of running the totally fraudulent Monticello U.) fraud used
weasel-word language with APICS
accreditation, something to the effect of "APICS-accredited schools are
viewed as equivalent to regionally
accredited programs", which was true of the two schools that APICS
bestowed accreditation without
being requested to do so... but, of course, it was true because the
schools were already legitimate,
not because of APICS. If you have any connections at the Universidad de
las Am ricas, I would highly
recommend notifying them that WAUC is a scam so they can take action to
have themselves removed
from WAUC's list (end of comments from John Bear).

My Post to CPU's Alumni Board (cc'd to SUI and Les Carr of CPU) on the
National Post article on
Senior U. (titled "Canada's National Post Calls Senior U. a Degree Mill"
To my recent surprise and shock the following article blasting Senior
University International
as a degree mill recently appeared in Canada's "National Post" - a major
Canadian daily
newspaper. I hope CPU takes a long hard look at the implications of this
upcoming merger
with SUI. Speaking subjectively, I personally do not wish to be seen as
associated with any
institution that is perceived publicly as a degree mill or otherwise
perceived as dubious. If CPU
should ever recover its reputation I hope it takes care to guard it with
due diligence and enter
only into associations that will serve that goal.
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

National Post Article:
Saturday, June 03, 2000 Would you like a degree with that pizza? That's
Dr. Seeman to you, by
Neil Seeman National Post Charles Rex Arbogast, The Associated Press.
You won't get anything
like this from a diploma mill. In fact, you may have trouble finding any
campus at all. A flustered
Janet Reno, the U.S. Attorney-General, this week urged Ministry of
Justice officials to study the
issue of false credentials after investigators were able to buy phony
accreditations from online
diploma mills. Government investigators had used fake I.D.s obtained on
the Internet to get past
security at 19 federal agencies, at the Pentagon and at two airports.
According to John Bear, the
credentials-for-cash problem is hardly unique to the United States.
Bear, the co-author of Bears'
Guide to Earning Degrees Nontraditionally, has been waging a one-man war
against diploma mills
for more than 20 years. One of his discoveries is that Canada has become
home to numerous
fly-by-night institutes of higher learning, many of which go to great
lengths to avoid the limelight.
"Several use addresses outside Canada such as Mellen University -- run
from Toronto with an
address in New York -- and Nova College (a.k.a. Farelston and Nova
College), run from Edmonton
but with addresses in Utah and the Channel Islands. And there is the
dreadful one-man Washington
University, run from Burnaby, B.C., but with an address in St. Louis
(where the real Washington
University is)," Bear notes. Diploma mills specialize in selling dubious
credentials, in law enforcement,
medicine, the humanities, almost anything. It is a lucrative business:
With hardly any overhead expenses,
the diploma mill industry worldwide is estimated at more than
US$200-million a year, with single schools
earning between US$10-million and US$20-million annually. Of course,
such institutions cater to our
obsession with credentials. In our ostensibly meritocratic society, the
right letters after one's name
open the same doors that a family name or connections alone once did.
Hence the scandals of recent
years involving people like Jag Bhaduria, the former Ontario Liberal MP
who was ousted from the party's
caucus in 1994 when it was learned he didn't have a law degree as he had
stated, or Jane Fulton, whose
fleeting career as Alberta's deputy health minister came to an abrupt
end in June, 1996, after it was
discovered she overstated her academic laurels. People like Bhaduria and
Fulton attract attention for
claiming degrees they didn't have. But Bear and other observers say that
thanks to the Internet, there
is now an enormous, burgeoning industry that makes it increasingly easy
for determined resume-burnishers
to obtain actual -- if meaningless -- degrees. Inspired by Reno's call
to action, I decided to compile my
own anti-guide to Canada's universities. My goal? To discover what is
the absolute worst, bedrock bottom,
school in Canada. The only difficulty was realizing just how stiff the
competition would be. --- Simply to
get in touch with a Canadian diploma mill, whose typical life span is
three months, you need to find an
anonymous source posted on an Internet newsgroup, send an email to the
source, then arrange for a
telephone call with a designated "career counsellor" on an untraceable
phone. It's all very mysterious --
and deliberately so. Why the secrecy? Most Canadian diploma mills live
in perpetual fear of periodic
CSIS investigations and journalistic exposes on shows such as 60
Minutes, which has run a documentary
on the subject. Hardly any have listed phone numbers. Alberta's Nova
College, for example, has a lone
post office box in the middle-class Calgary suburb of Northland Village.
(The extreme may be Harrington U.:
Run from California, it has its mailing address at a mailbox service in
London, its bank is in Limassol, Cyprus,
and its printing plant is in Jerusalem.) Senior International
University, however, which is located in Richmond,
B.C., with a business Office at the Lifelong Learning Center in
Evanston, Wyo., prides itself on being a
"university of open doors," according to the mission statement posted on
its Web site (www.senioru.edu).
Senior is what Bear calls a "grey area" school, offering wildly dubious
degree programs under the trappings
of authenticity. Nusri Hassam, the school registrar, puts it slightly
differently: Senior, she said, simply offers
"a highly individualized model." "If you're lucky," she said, "you can
train with the eminent Dr. Hassam himself."
Dr. Abdul Hassam, she informed me, was a world-renowned authority in the
paranormal. "You know, like Fox
Mulder of The X-Files." As a test of Senior's exacting standards, I
decided to adopt a persona with the worst
academic record I could think of. "Holden Caulfield. What a most curious
name," Ms. Hassam said when
I pretended to be J.D. Salinger's sardonic anti-hero and enquired about
the university's "school of
consciousness studies and secret traditions." (Last time anybody heard
from the protagonist of The
Catcher in the Rye, he had flunked out of high school after losing the
foils for the fencing team, of which
he was captain, on the Long Island subway.) Being Holden Caulfield, it
turned out, was no barrier whatsoever.
But could they grant me a PhD in psychology; specifically, in alien
studies? "No problem," said Ms. --"Ahem,
that's Doctor, actually" -- Nusri Hassam, who is an admitted acolyte of
Dr. Abdul Hassam, "who is very much
into consciousness-studies." Nusri Hassam explained that for a fee in
the $1,000-plus range -- which is
often negotiable -- students write a one-to-three-page proposal about
their preferred course of study. The
student is then placed under the tutelage of a like-minded mentor, asked
to complete a series of readings,
and then rigorously assessed, in a kind of "academic defence," on his or
her knowledge of those readings --
over the phone or on e-mail. "If you put in a tremendous amount of
work," the registrar said, "you can get
your degree in alien studies in one year." "Is this a joke?" I asked.
"No, we're officially recognized by the
PPSUC, a degree-granting authority," she explained, "under the auspices
of the state of Wyoming." "What
about the fact I never even really graduated from high school?" I asked
Judy, Senior International's receptionist.
"No problem! We evaluate the whole person," she explained chirpily. "We
have lots of students who have taken
different programs in different places. But without high-school, things
may take a little longer," she conceded.
"How much longer?" I asked in a tone of grave concern. "At the very
longest, a year," she quickly reassured
me. Senior's modus operandi is illustrative of what most diploma mills
offer: negotiable fees, super-accommodating
administrative staff and hilariously light-weight academic standards. In
that regard, Senior is following in the proud
tradition of what may be Canada's best-known and most ambitious diploma
mill, Calgary's "College of Technology,"
which shut down two years ago after a flurry of customer complaints.
Calgary Tech offered bachelor's degrees,
master's degrees and doctorates for the bargain-basement price of $275
apiece -- which would have made it the
best deal around for a quick and dirty degree if it still existed. The
campus literature described the dean, Colonel
R. Alan Munro, as "Canada's premier Aeronaut." (As hard as I tried, I
could not find the definition of an 'aeronaut'
in any English dictionary. It is doubtless a prestige profession.) "The
Calgary College of Technology was run out
of Spiro's Pizza Parlour," says Bear, describing the school's uniquely
studious environment. He proffers jokingly
that "PhD" actually stood for "Pizza, Home Delivery." Today, the torch
of academic excellence has passed from
Col. Munro to Egbert Phipps, MD, PhD, MSc, BSc (all degrees from the
London-based Royal Society of Health),
who runs the Alternative Medicines Research Institute (AMRI) in
Vancouver. How does the Institute compare to
Senior? Phipps promises prospective students a doctoral degree in
alternative medicine as fast as they can
dispatch their resume and a letter detailing their enthusiasm and
research experience in the much-misunderstood
field of the "laying on of hands." "Many people don't hold much stock in
the laying on of hands," explains Phipps.
"But not me, I'm a huge believer." After interested students fire off
the required paperwork, AMRI promises two
standard transcripts, complete with concocted grades, and an official
letter confirming successful completion of
the degree requirements. All this costs only $650 -- one of the best
bargains anywhere, and easily besting Senior.
"Our awards-granting committee just met last week," said Phipps, "and we
agreed that most doctoral programs
charge too much money and insist on way too much study for a degree. So
we decided to lower our price substantially,
" he said invitingly. But what kind of a job can students expect with a
PhD in holistic medicine from the Alternative
Medicines Research Institute? "Well, when it comes to laying on of
hands, most of us are self-employed," sighed
Phipps. "Although," he added hopefully, "the trend these days is to move
toward group practice." A mere week
after speaking with Phipps I received a congratulatory letter embossed
with a fake gold stamp. My voice mail and
e-mail mentioned my real first name, and I was forced to use "Neil" in a
series of back-and-forth messages to the
Institute to prove my bona fides: So Phipps's letter was addressed to
"The Most Honourable Doctor Neil Caulfield."
I had passed already! Even without seeing any of my qualifications,
Phipps was "pleased to convey the
recommendation of The Board of Directors and Trustees to award you the
Doctor of Philosophy degree specializing
in Holistic Medicines." My telephone manner had clearly impressed him.
But he would be even more impressed,
he wrote, if I shelled out US$550 for the "Committee's review fees" in
addition to "processing and graduation fees"
of US$100. Since Calgary Tech is now defunct, this means AMRI is the
best deal in Canada for a quick and dirty
degree. When he's not busy laying on hands, it seems, Phipps runs
another Vancouver-based diploma-mill,
George Washington University, Inc., which offers degrees at the
Bachelor's, Master's, and Doctorate levels --
also without the irritation of real coursework. Yet despite the best
efforts of Phipps and others, Canada is still
in grade school compared with the United States when it comes to diploma
mills. Though doubtless wacky,
places like Senior and the Alternative Medicines Research Institute are
fairly innocuous in their marketing and
basic pedagogical methods (i.e. qualifications + money =
matriculation). By contrast, U.S. institutions like
Century University enjoy putting subtle ads -- "Many fields; no classes;
NO COST evaluation!" -- in such
venerable publications as The Economist. Kathy, a receptionist at
Century's head office (really a suite in
Albuquerque, N.M.), assured me, back in the persona of Holden, that my
abysmal performance in high
school was no barrier to obtaining a bachelor's degree in one year and a
doctorate in two. "Don't worry,
Mr. Caulfield. You sound really intelligent. And you say you've got work
experience? Don't worry, we
account for all of that stuff," she cooed. Eric Hecksler, the dean of
psychology at Honolulu's Pacific Western
University, one of the granddaddies of diploma mills, told me he had
just the ticket. Hecksler, who
professes to be a "Stafford-educated psychologist," advised me he "knows
all about interpersonal
relationships, and gender stuff too, possibly the most important field
of psychology today." The best
part about the Pacific Western degree is that, within just 48 hours --
assuming you have sufficient personal
experience of course -- you will know how soon you can get your
doctorate degree. Which can take as
little as six months, maybe less, said Dr. Hecksler. The downside? You
have to pay US$5,000 and write a
gruelling 35-page thesis. (A real PhD, even at many of the elite U.S.
Ivy League schools, may not even cost
that much, once you factor in scholarships, teaching stipends, bursaries
and grants. But a real doctorate
requires serious work: usually two years of coursework and periodic
teaching stints, followed by two years
of writing an original thesis, which must be defended before a committee
of senior academics in the field.) An
even better option for Holden might be a combined bachelor's, master's,
and doctorate degree in metaphysics,
to be completed in a year or less. That is the latest offering from the
University of Metaphysics in Studio City,
Calif., whose administrator, Shirley Lawrence, calls it an "unbelievable
deal." I agreed. Yet it's not quite as
unbelievable as The Bernadean University, in Chatsworth, Calif. -- it
used to offer its graduates a doctoral
certificate absolving them of all their past sins. Aside from elusive
hopes of salvation, and the cheap and
exponential marketing power of the Internet, why do diploma mills
prosper so? Psychologists generally
agree that people lie about their credentials in order to be more
accepted in society. Diploma mills, it
seems, answer that visceral need. Holden Caulfield, describing his high
school, Pencey Prep, gets
closest to this truth: "You probably heard of it. You've probably seen
the ads, anyway. They advertise in
about a thousand magazines, always showing some hot-shot guy on a horse
jumping over a fence." No
matter who we are, it seems, we all strive to be that guy on the horse,
the phony with the gleaming smile
and the perfect hair and the beautiful girl hugging him from behind --
even if we know him to be a chimera.
Is that so bad? Probably not. But one thing diploma mills teach is that
a piece of paper alone may not
necessarily cure us of our insecurities. Perhaps the one thing they do
sell is the true meaning of caveat
emptor -- a phrase first put in print in 1523 by Sir Anthony
Fitzherbert. He was, according to his biographer,
an Oxford-educated judge -- even though no evidence of this exists.



To: DanZ who wrote (4732)10/19/2003 9:31:21 PM
From: StockDung  Respond to of 5582
 
DAVIDSON'S NEW VENTURE meditrimorders.hypermart.net

====================================================
Exciting new medical weight-loss Breakthrough!

MD STUDY ANNOUNCES
RECRUITING QUALIFIED VOLUNTEERS FOR
NEW CONTINUATION WEIGHT LOSS STUDY
USING YOUR SENSE OF SMELL TO LOSE WEIGHT

Eat as much of your Favorite Foods as you want
and Lose Weight



REQUIRES ---
NO DIET! NO HUNGER! NO WILLPOWER!
NO CALORIE COUNTING
NO FAT GRAM COUNTING
NO CHANGE IN EXERCISE HABITS


Are you 18 years of age or older?
Are you trying to lose weight? 5, 10, 50 … 100 pounds?
Do you have a normal sense of smell?
Do you want to lose weight without dieting, without counting calories, without feeling hungry?
If you’ve answered YES to these questions, you may qualify to participate in the MD Weight-Loss Study

You must call TOLL FREE – 24 Hours/day – 1-877-MD STUDY (1-877-637-8839)
or send the email and we will contact you by phone



The world’s first weight-loss study using your sense of smell may have uncovered the elusive key to SIMPLE, SAFE and LASTING weight loss without dieting, deprivation, or making changes to your exercise routine.
The just released study is published in the Journal of Advancement in Medicine (volume 12, Issue 1 – Spring). This scientific, double-blind controlled study reveals that subjects using specially formulated scents lost 500% more weight in the 16 weeks study without dieting than the control group who did not use the specially formulated aromas.
In addition, the study showed that simply inhaling these specially formulated aromas decreased cravings for food by 50% within five minutes of use and strongly decreased appetite resulting in a "full" feeling.

All the research was performed by the researchers at BioTem Cytotechnologies’ Human NeuroSensory Laboratory in California. Their study proves conclusively and scientifically, that inhaling specially formulated scents before and after eating – without dieting or exercising – results in significant weight loss.

Now, researchers are seeking qualified volunteer participants to take part in the continuation of that breakthrough medical MD Study. Duration of study is twelve (12) months. All selected study participants will have an MD available for discussion purposes and will receive the product not just for the duration of the study but as long as needed beyond the study time frame.

If you would like to learn more about the study and are interested in a FREE screening to learn if you qualify to be a participant in the MD Study, please call TOLL-FREE: 1-877-MD STUDY (1-877-637-8839) or send the attached E-mail and we will contact you by phone.



To: DanZ who wrote (4732)10/20/2003 10:06:53 AM
From: StockDung  Respond to of 5582
 
scan.cch.com



To: DanZ who wrote (4732)10/20/2003 1:18:58 PM
From: StockDung  Respond to of 5582
 
Phil Gurian and Phil Abramo Soveriegn's secret owners pay a visit to their broker
=-============================

On May 25, 1996, Hauchecorne learned who some of them were. While he was staying at the upscale Drake hotel in Manhattan, four men burst into his room and accosted him. One was a client he knew by name as Louis Metzer, although the two had never personally met. When “Metzer,” whom he described as a “big muscular guy,” burst into the room, Hauchecorne recognized him from a BusinessWeek photo as Philip Abramo, a high-ranking member of the Mafia. With Abramo was Philip Gurian, another mob-connected figure who placed dozens of orders with Hauchecorne to buy and sell US stocks, many of which had been identified by BusinessWeek as mob-manipulated stocks. Hauchecorne described the other two as “little Italian-looking guys” who served as hit men. One had a gun in his belt and the other was brandishing a steel bar. They demanded that Hauchecorne return $1.75 million he had transferred to Switzerland on the instructions of another Mafia operative, Eric Wynn, who had had a falling out with Abramo and Gurian. Otherwise, they would kill him. “I was scared shitless,” the baby-faced broker admitted. “I do a lot of sport stuff, bungee jumping and #### like this, and I have enjoyed that. But this is the first time where I knew, this is it, you’re lucky if you walk out of here.”

Later, in a more civil attempt to recover the funds, Gurian filed a statement of claim in Alberta Court of Queen’s Bench. The matter was eventually settled out of court, but it came to the attention of officials working for the Vancouver Stock Exchange, who cited Hauchecorne for failing to learn “the essential facts” of the accounts he was operating. In June 1999, a VSE hearing panel ruled the Pacific International broker had failed to make necessary inquiries to determine whom he was dealing with. Noting that Hauchecorne had worked in the investment business for 10 years, the panel concluded “he was sufficiently experienced to know that offshore companies could be used for illegal activities.” The panel suspended his broker’s licence for life, fined him $200,000, ordered him to disgorge $95,000 in illicit commissions and pay investigation and hearing costs. In assessing these penalties, the panel said there was no question that Hauchecorne’s misconduct deserved serious sanctions, but noted there were no similar precedents to serve as guidelines. “This case seems to us to be a unique one and stands alone,” it noted.

===================================
Troubled waters

Pacific International is under the microscope of the BC Securities Commission, which alleges some of its officers and directors turned a blind eye to mob-related transactions

Vancouver stockbroker Jean Claude Hauchecorne, who worked at Pacific International Securities Inc. until mid-1999, had a charming personality, and his boyish looks made him the picture of innocence. As one colleague said, “You would never suspect him of doing anything wrong. He had a good sense of humor; it was hard not to get along with him.”

Hauchecorne was, however, a risk taker. He liked flying small planes and was an avid hang glider and bungee jumper. But even more dangerously, he didn’t care whom he dealt with. Born in Switzerland and fluent in four languages, the 41-year-old broker worked as a functionary in the classic Swiss tradition. He didn’t try to analyze stocks, and rarely recommended them. He was simply an order taker, who bought and sold on clients’ instructions. He didn’t always know who his clients were, nor did he bother to find out. He didn’t think it was his business or duty.

On May 25, 1996, Hauchecorne learned who some of them were. While he was staying at the upscale Drake hotel in Manhattan, four men burst into his room and accosted him. One was a client he knew by name as Louis Metzer, although the two had never personally met. When “Metzer,” whom he described as a “big muscular guy,” burst into the room, Hauchecorne recognized him from a BusinessWeek photo as Philip Abramo, a high-ranking member of the Mafia. With Abramo was Philip Gurian, another mob-connected figure who placed dozens of orders with Hauchecorne to buy and sell US stocks, many of which had been identified by BusinessWeek as mob-manipulated stocks. Hauchecorne described the other two as “little Italian-looking guys” who served as hit men. One had a gun in his belt and the other was brandishing a steel bar. They demanded that Hauchecorne return $1.75 million he had transferred to Switzerland on the instructions of another Mafia operative, Eric Wynn, who had had a falling out with Abramo and Gurian. Otherwise, they would kill him. “I was scared shitless,” the baby-faced broker admitted. “I do a lot of sport stuff, bungee jumping and #### like this, and I have enjoyed that. But this is the first time where I knew, this is it, you’re lucky if you walk out of here.”

Later, in a more civil attempt to recover the funds, Gurian filed a statement of claim in Alberta Court of Queen’s Bench. The matter was eventually settled out of court, but it came to the attention of officials working for the Vancouver Stock Exchange, who cited Hauchecorne for failing to learn “the essential facts” of the accounts he was operating. In June 1999, a VSE hearing panel ruled the Pacific International broker had failed to make necessary inquiries to determine whom he was dealing with. Noting that Hauchecorne had worked in the investment business for 10 years, the panel concluded “he was sufficiently experienced to know that offshore companies could be used for illegal activities.” The panel suspended his broker’s licence for life, fined him $200,000, ordered him to disgorge $95,000 in illicit commissions and pay investigation and hearing costs. In assessing these penalties, the panel said there was no question that Hauchecorne’s misconduct deserved serious sanctions, but noted there were no similar precedents to serve as guidelines. “This case seems to us to be a unique one and stands alone,” it noted.

If the case did stand alone, it wouldn’t for long. In succeeding months, US authorities filed numerous complaints alleging that Pacific International accounts were being used as turnstiles for money-laundering activities and illicit stock activities in the US and offshore. In fact, the cases became so numerous that BC Securities Commission (BCSC) investigators began to look beyond Pacific International’s rank-and-file brokers to the people who were running the firm. That investigation culminated on July 10, 2001, when BCSC executive director Stephen Wilson issued a notice of hearing alleging that nine of Pacific International’s senior officers and directors had turned a blind eye to mob-related share dealings and money-laundering activities.

The notice cited the Hauchecorne case and named 14 other men “with criminal or regulatory histories” who had controlled, operated or were associated with accounts at Pacific International. It also referred to numerous indictments and complaints filed by the US Department of Justice and the Securities and Exchange Commission (SEC) that had cited instances where illicit transactions had occurred in Pacific International accounts. All these cases, the commission contended, should have prompted the firm to conduct internal reviews and “address the compliance deficiencies which those reviews should have revealed.”

The list of respondents reads like a who’s who of Howe Street. Among them:

Pacific International chairman and founder Max Meier, a 55-year-old Swiss native who served as a member of the VSE board of governors for 10 years, including a stint as vice-chairman from 1994 to 1997.

* Cofounder and vice-chairman John Eymann, who served as a member of the BCSC policy advisory committee, is a member of the Canadian Securities Institute’s ethics committee and a member of numerous VSE disciplinary panels.

* Former Pacific International chairman and director Marty Reynolds, a former Nesbitt Burns executive who served as VSE chairman from 1989 to 1991.

* Compliance head Larry McQuid, a former RCMP commercial crime officer and ex-VSE compliance manager who served on the VSE board of governors for several years.

* President and COO Jean-Paul Bachellerie, a BC chartered accountant.

But there was a much bigger fish caught in the commission’s net: Germain Carriؘ, president and COO of National Bank Financial Ltd., a wholly owned subsidiary of National Bank of Canada. Several years earlier, National Bank Financial had acquired a 35% stake in Pacific International and Carriؘ had joined the board to keep an eye on the bank’s investment. Now he found himself the subject of securities commission action. “We have named all the directors because they bear the ultimate responsibility for what happens at the firm,” Sasha Angus, BCSC director of enforcement, told reporters.

On Sept. 6, Carriؘ settled the allegations against him by admitting he had become aware of “certain deficiencies” in Pacific International’s compliance procedures, and some of the trading that had occurred had “harmed the reputation of the capital markets in British Columbia.” He agreed to pay a $1,000 penalty and $4,000 in investigation costs. (The settlement acknowledges Carriؘ had been a director only since May 1998, after most of the offending transactions had occurred, and that in June 1999 the firm, under his leadership, began a major effort to clean up its compliance procedures.)

The remaining respondents have been ordered to appear before a commission tribunal on Oct. 7 for a hearing that is expected to take months. If found to have failed to live up to their duties, they could be exiled from the market, fined up to $100,000 each and ordered to pay costs. “What we are trying to address is the necessity of proper compliance procedures not only being in place but also being followed,” said Angus. “You must know who your client is and why they are at your firm and what they are doing at your firm.” John Woods, editor of Canada Stockwatch, a Vancouver-based stock market information service, had a blunter description of what the notice was all about: “They are accusing the heart of the Howe Street brokerage fraternity of governing in the spirit of the three monkeys.”

This wasn’t the first time Pacific International had come to the attention of regulators. Over the years, the firm’s brokers had been involved in myriad misdealings. In July 1999—a month after Hauche-corne was exiled from Howe Street— The Vancouver Sun conducted a review of disciplinary actions the VSE had taken against the 18 securities firms under its audit jurisdiction. It found that, from January 1995 until then, Pacific International had amassed a league-leading $999,200 in fines and costs, and its brokers had been hit with a total of 75 years in suspensions, second only to Georgia Pacific Securities, another small Howe Street brokerage firm. (For the purpose of the study, Hauchecorne’s lifetime suspension counted for only 25 years.) Most of these actions stemmed from dealings in the US penny stock market, which had become Pacific International’s bread and butter after Michael Johnston was appointed VSE president in 1995 and drove most of the scurrilous promoters south to the loosely regulated OTC Bulletin Board. According to the BCSC, in 1993 the firm derived $2.3 million, or 14% of its commission revenue, from stocks traded or quoted in the US. By 1999, that figure had jumped to $19.2 million, or 67% of overall commission revenue. Of this amount, 82% was gener- ated by 15 of Pacific International’s 85 brokers, and 80% came from non-resident accounts. Meier made no secret of his firm’s predilection for risky business. “We go where our clients want to go and obviously in the last few years a lot of clients have gone to the Alberta Stock Exchange, Canadian Dealing Network and bulletin board,” he said in an interview in January 1999 (before the VSE merged with the ASE and CDN to form the Canadian Venture Exchange). “We don’t recommend stocks in those markets, but there seems to be a lot of people who want to be involved in them.”

Despite recurring regulatory problems, Pacific International had managed to remain a VSE member in good standing. Indeed, the firm’s status was high enough that in May 1998, Montreal-based LúBsque Beaubien Geoffrion Inc. acquired a 35% interest in it. At the time, LúBsque was 75% owned by National Bank Financial Ltd., which, in turn, was wholly owned by the National Bank of Canada, also based in Montreal. That meant National Bank had a 26% indirect interest in Pacific International. In August 1999, LúBsque acquired First Marathon Securities and renamed the merged entity National Bank Financial. At the same time, National Bank acquired the remaining 25% of LúBsque, increasing its interest in Pacific International to 35%.

The combined LúBsque/First Marathon operations, with 2,700 employees in 86 of-fices across the country, are now operating as National Bank Financial. Pacific International, with 155 employees in three offices in Vancouver, Victoria and Calgary, continues to operate separately under its own name. In Vancouver, both firms are located in the prestigious Park Place building on Burrard Street, albeit on different floors. Pacific International, however, proved to be one of the bank’s less prestigious affiliates. After the Hauchecorne incident, there was a flood of other cases citing Pacific International as a conduit for illicit activities. One in particular would capture headlines across the country.

The basic modus operandi of stock manipulators is to acquire big blocks of cheap shares in a shell company, stash the shares in offshore accounts, issue false information on the company’s commercial prospects, bribe brokers and newsletter writers to recommend the stock to their clients, then dump shares onto unsuspecting investors and run away with the cash. Woods of Stockwatch says Vancouver brokerage firms are favorite places to stash stock because their employees “wake up in the morning, put their noses into the air, smell manure and head straight to it.” As he sees it, the brokers are happy to take the business because it is easy and lucrative. “All you are is an order taker,” he says. “The commissions to the broker and the member firms are absolutely mind-boggling.” But he notes that some of the order takers have made a critical mistake. “They think because Vancouver brokerage firms are offshore, US authorities can’t get to the bottom of them. Well, oops.”

On June 29, 1999, Pacific International brokers Michael Patterson and Dirk Rachfall crossed the US border at Blaine, Wash., just south of Vancouver, and drove to a restaurant near the Sea-Tac International Airport outside Seattle. There they met a client, David Hogue of New York, with whom they were ostensibly going to play a game of golf. They never got to hit any balls, though. As the brokers were chatting, several FBI agents burst onto the scene and arrested Patterson and Rachfall. Hogue was not arrested. He was, in fact, working with the feds. It had been a setup.

According to a complaint filed days earlier by an FBI agent in New York, Hogue had routinely bribed brokers to sell stocks to the public on the basis of false and misleading statements. One of the stocks was Orlando Supercard Inc., an OTC Bulletin Board stock that, according to the US Justice Department, was being manipulated through Hogue’s accounts at Pacific International by members of the New York-based Colombo crime family and a Russian organized crime group called Bor. By August 1997, however, the scheme had collapsed, leaving Patterson and Rachfall with a $300,000 debit for which they were personally responsible. To correct the debit, the brokers enlisted Hogue to help them corral the company’s shares, artificially inflate the share price and deal them off to the public. Unfortunately for the brokers, Hogue was caught and pleaded guilty to stock manipulation. In return for leniency, he agreed to become a co-operating witness. After their arrest, Rachfall and Patterson were placed in custody and indicted by a US federal grand jury in New York. Pacific International was not accused of any wrongdoing. Within several days, Rachfall was released on US$300,000 cash bail and Patterson on US$350,000 cash and property bail. Of those amounts, Pacific International kicked in $50,000 each from monies that they had available to them within their firm. “We did that out of compassion for their wives and children,” explained McQuid, the firm’s compliance officer.

In April 2000, the brokers pleaded guilty to one count of securities fraud in the US and were imprisoned for five months and fined US$130,000 each. Then they returned to Vancouver.

In July 1999, days after the Rachfall and Patterson case hit the news, Pacific International was broadsided by another indictment, this one filed in US District Court in New Jersey. A US Justice Department attorney alleged that promoter Philippe Hababou, who had been a fugitive from French justice since the mid-1990s, and several of his nominees acquired control of another OTC-listed company, Prime International Products, then arranged for the company to issue large blocks of stock to offshore companies that they also controlled. Some of this stock was allegedly deposited into accounts at Pacific International in the names of Hababou and several nominees, enabling them to control about two million free-trading shares without any disclosure to US regulators or prospective investors. They then made false statements about the company to induce investors to bid up the stock, enabling them to sell US$5.3 million worth. Of this amount, Hababou allegedly transferred US$2.2 million to accounts at Citibank in New York and US$580,000 to an account in his name at Caesar’s Atlantic City Casino in New Jersey. Although Pacific International was allegedly used as a conduit, there were no allegations of misconduct against the firm.

Hababou’s broker at Pacific International was Donald Bruce Stratton. He had worked at the firm since 1987, but had taken a leave of absence on May 26—just three weeks before Hababou was indicted for alleged stock manipulation and money-laundering. McQuid said Stratton was on a cross-country motor tour of Canada and was due back within three months. The indictment threw BCSC’s Angus into a high state of excitement. “This is a great concern for our market,” he said, convinced he was dealing with something more than a few errant accounts.

Even more concerned was his new boss, Stephen Wilson, former head of Hong Kong Bank of Canada’s mutual fund arm. Wilson had taken office as executive director of the BC Securities Commission in July 1999, and had been watching the parade of crooks that had been passing through Pacific International. In September 1999, during his inaugural interview with The Vancouver Sun, he made it clear that he was looking for a new ethical standard on Howe Street. Wilson said he wanted to change the mindset of “extreme entrepreneurialism” that pervaded the securities industry. “The profit motive is so strong it places the compliance motive into a distant second place,” he declared. “I want them [brokers and other registrants] to think about operating in a compliant way, rather than just a cost of doing business. Compliance is not a function, it’s a state of mind. Either the firm, from top to bottom, behaves in a compliant way or it doesn’t.” Wilson said brokerage firms must take more responsibility for the actions of their employees. “If a broker screws up, the broker gets shotgunned and the firm carries on,” he noted. “I find that extraordinary.”

But it wasn’t. For years, many of Howe Street’s more dubious brokerage firms had been able to survive repeated scandals by tossing their brokers onto the regulatory altar. The VSE and its successor, the Canadian Venture Exchange (now the TSX Venture Exchange), had routinely suspended and fined rank-and-file brokers, but rarely penetrated the paneled boardrooms of the firms themselves. Making it clear that his comments were not philosophical musings, Wilson referred specifically to Pacific International, but added that the commission was not restricting inquiries to that firm. “We are also investigating the broader implications of the Pacific International affair,” he said.

Meanwhile, Pacific International was shifting into full damage control. On July 7, just as the Hababou case was surfacing, the brokerage issued a release noting that the indictment contained no allegation of wrongdoing against the firm or any of its employees. Furthermore, the release said, the indictment named not only Pacific International as an intermediary for illicit transactions, but also a “sizeable brokerage firm” and a New York bank. “Our compliance checks exceed industry requirements,” the release quoted McQuid as saying. “Nonetheless, we have launched a complete and independent review of all our compliance measures.”

Three days later, Pacific International announced it had hired a high-powered independent team to review its compliance procedures. The team consisted of Mark Skwarok, former chief counsel for the BC Securities Commission, Dean Holley, former executive director of the commission, and Norman Inkster, former RCMP commissioner and now president of KPMG Investigation and Security Inc. “We are obviously concerned about these incidences and the perceptions they leave with the investing public and securities regulators,” said Pacific International chairman Meier.

The following month, the firm an-nounced “bold new compliance initiatives” to reduce the possibility of it being used by US clients as a conduit for illegal purposes. According to Pacific International, it had already established “some of the most stringent account opening and identity verification procedures in the industry.” Henceforth it would not allow US residents to open accounts, or permit share certificates of companies quoted on the OTC Bulletin Board to be deposited into client accounts, or allow non-resident clients to transfer funds or securities to third parties. “Our goal is simple,” said Meier. “We want to minimize the risk that our firm could be used in the future as a conduit for questionable activities.” After Rachfall and Patterson returned to Vancouver, Wilson hauled them before a commission hearing panel. He wanted them banned from the stock market for the next 20 years, fined $50,000 each and assessed costs. However, the tribunal had different thoughts. “Considering the consequences that Rachfall and Patterson have suffered as a result of their conduct, it is unlikely they would pose a threat to the market were they to rejoin the securities industry,” the panel decided. “If anything, their experiences should make them unusually vigilant.” Woods of Canada Stockwatch thought the panel’s reasoning was “ridiculous.” Referring to the pair’s efforts to resolve their debit problem, he suggested they had “already demonstrated they will do anything to get out of a jam. They are convicted crooks. The very idea that a convicted crook is a rehabilitated crook is ludicrous.” Wilson wasn’t too thrilled with the verdict, either. “I’d be lying if I didn’t say I was disappointed with the gap between what we were asking for and what we were given,” he said. Throughout 2000 and 2001, US authorities issued more indictments and complaints against promoters who used Pacific International as a vehicle for their alleged frauds. By July 10, 2001, when the commission issued its notice of hearing, it was able to name 14 people with regulatory histories who directly or indirectly ran accounts there. The most serious offender was Shalom Weiss, who was indicted in Orlando, Fla., in April 1998 on racketeering and money-laundering charges. The following year, he was convicted and sentenced to 845 years in jail and ordered to pay more than US$100 million in restitution to his victims. Meier insists that nobody at Pacific International had any idea Weiss was involved in any accounts at the firm. In fact, he says they never heard of him until a year or so after the account was closed. More generally, Meier says that any suggestion the firm’s directors did not meet their corporate governance responsibilities is “unwarranted and unfair, particularly to those directors who did not have direct compliance responsibilities.” Indeed, it is clear from the lineup of lawyers that Meier and his fellow directors place themselves in a different category than McQuid, who had direct-line responsibility for compliance. (The directors are represented by well-known Vancouver securities lawyer Don Sorochan. McQuid has separate counsel, Skwarok.) Whether McQuid becomes the sacrificial lamb, or Wilson succeeds in establishing a new standard of corporate governance on Howe Street, remains to be seen.



To: DanZ who wrote (4732)10/20/2003 3:02:08 PM
From: StockDung  Respond to of 5582
 
DAN, WHY SO MUM? WHERE MY NUMBERS OFF? Message 19415609

OR IS WHAT I STATED 100% CORRECT?

BETER YET, IS WHAT YOU STATED 100% CORRECT?



To: DanZ who wrote (4732)10/21/2003 9:31:43 AM
From: StockDung  Respond to of 5582
 
Botanical Laboratories, Inc., which distributed Natra-Bio products, was ordered
to stop claiming that BioAllers was a homeopathic remedy for reliving symptoms
of allergy due to pollen, animal hair, dander, mold, yeast, and dust. The
products were promoted as homeopathic even though some ingredients were not in
the Homeopathic Pharmacopeia. groups.google.com



To: DanZ who wrote (4732)10/21/2003 9:41:30 AM
From: StockDung  Respond to of 5582
 
TESTIMONIALS THAT YOU WILL NOT FIND ON ZICAM'S WEB SITE. PLUS A CALL TO FULL DISCLOSURE OF CORPORATE INVESTMENT BANKING SHANANAGANS
===================================================

ZICAM™ Cold Remedy MEDICAL TESTIMONIALS:

"The nasal mucosa is an excellent route for drug delivery without systemic side effects, especially when treating conditions that originate in the nasal cavity, such as the common cold."

Fariba Ghodsian, Ph.D.
Drug Delivery Systems Expert
Los Angeles, CA


web.archive.org

=============================================

Zengen, Inc - Zengen shareholders elect board of directors; ...
... He led the marketing team that took Zicam™ from an unknown entity to one of the ... Fariba
Ghodsian Dr. Ghodsian
joined the Company's Board of Directors in 2000. ...
zengen.com - 12k - Cached - Similar pages

=========================================

"Fariba Ghodsian
Dr. Ghodsian joined the Company's Board of Directors in 2000. Dr. Ghodsian is currently Managing Director and Director of Healthcare Research at Roth Capital Partners. She has been a scientist, director of business development, acting chief financial officer and board member in privately and publicly held biotechnology and pharmaceutical companies, such as Allergan, MedClone and Trega Biosciences. She was Vice President and Senior Biotechnology Analyst for several investment-banking firms, including Lehman Brothers, Hancock Institutional (Sutro and Tucker Anthony) and Wedbush Morgan Securities. Dr. Ghodsian received an MBA from UCLA, a Ph.D. in Biomedical Engineering from Oxford University, an M.S. in Chemical Engineering from MIT and a B.S. in Chemical Engineering from Technion, Israel Institute of Technology."

Zengen shareholders elect board of directors; approve equity compensation plan

WOODLAND HILLS, CALIF. (July 11, 2002) — Zengen, Inc. held its Annual Shareholders Meeting today at which shareholders re-elected a Board of Directors and approved the Company's 2002 Equity Compensation Plan.

The Shareholders elected the following directors at the Annual Meeting

K. Bobby Chao
Mr. Chao began his career as one of the five original founders of Cadence Design Systems. A year after Cadence's successful initial public offering, Mr. Chao founded Ocron, a leader in optical character recognition technology and document management software. Mr. Chao was chairman and chief executive officer of Ocron until Umax Technologies, Inc. acquired it. He then became part of the Umax team serving as senior vice president of marketing in charge of corporate marketing and investment. Mr. Chao was previously general partner for Technology Associates Management Company and has served as chairman and chief executive officer of VA Linux Systems. Mr. Chao is currently on the board of several companies and professional organizations as well. Mr. Chao holds an MS in Physics from Georgia State University and an MS in Aeronautics Engineering from Stanford University.

R. Steven Davidson
Dr. Davidson has been the Company's President and Chief Executive Officer since January 2002 and a director since April 2002. Dr. Davidson has over eight years of experience in the biopharmaceutical industry. From September 1998 to December 2001, Dr. Davidson was the chief executive officer and a director of Gel Tech, LLC. At Gel Tech, Dr. Davidson raised capital for the market launch and distribution of the Zicam™ cold remedy. He led the marketing team that took Zicam™ from an unknown entity to one of the top medications in its class. He also implemented and launched line extensions to strengthen brand name and increase company value. During this period, Dr. Davidson was also the managing director of Biodelivery Technologies, Inc. From October 1994 to August 1998, Dr. Davidson was the chief executive officer of Biotem Cytotechnologies, Inc., a biopharmaceutical research and development company. Dr. Davidson received his MBA in International Finance and Ph.D. in Biopharmaceutical Project Management from the American University of Asturias.

Errol De Souza
Dr. De Souza was appointed to the Scientific Advisory Board in 2000. In 2001, he joined the Company's Board of Directors. Dr. De Souza is currently Senior Vice President and Site Head of U.S. Drug Innovation & Approval, a Division of Aventis. Previously he was: Director of Central Nervous System Diseases Research at the Du Pont Merck Pharmaceuticals; Founder, Director and Executive Vice President of Neurocrine Biosciences, Inc. and President, Chief Executive Officer and Director of Neuroscience Pharma, Inc. Dr. De Souza has edited 5 books and is an author or co-author of approximately 250 original articles, chapters or reviews. He is the recipient of numerous national and international awards. Dr. De Souza has served on several Editorial Boards and National Institutes of Health Committees. He has a Ph.D. in Neuroendocrinology from the University of Toronto in Toronto, Canada.

Fariba Ghodsian
Dr. Ghodsian joined the Company's Board of Directors in 2000. Dr. Ghodsian is currently Managing Director and Director of Healthcare Research at Roth Capital Partners. She has been a scientist, director of business development, acting chief financial officer and board member in privately and publicly held biotechnology and pharmaceutical companies, such as Allergan, MedClone and Trega Biosciences. She was Vice President and Senior Biotechnology Analyst for several investment-banking firms, including Lehman Brothers, Hancock Institutional (Sutro and Tucker Anthony) and Wedbush Morgan Securities. Dr. Ghodsian received an MBA from UCLA, a Ph.D. in Biomedical Engineering from Oxford University, an M.S. in Chemical Engineering from MIT and a B.S. in Chemical Engineering from Technion, Israel Institute of Technology.

James Lipton
Dr. Lipton has been the Company's Chief Scientific Officer and a Director since April 2000, after the Company's merger with Abitis, LLC, a biotechnology research and development company that he co-founded with Matthew C. Lipton, our Chief Operating Officer. Dr. Lipton is the named inventor on multiple patents related to a-MSH peptides. From 1966 to 2000, Dr. Lipton held positions, including professor of Physiology and Anesthesiology and Pain Management at the University of Texas - Southwestern Medical Center at Dallas, Texas. Dr. Lipton currently serves as Visiting Professor of Internal Medicine at the University of Milan Medical School in Milan, Italy. Dr. Lipton received his Ph.D. from the University of Colorado. He was awarded post-doctoral grants at the University of Michigan Medical School and a Special Research Fellowship at the Institute of Animal Physiology in Cambridge, United Kingdom. Dr. Lipton has more than 20 years experience in the pharmaceutical industry and has participated in numerous research projects funded by the National Institute of Health, the Department of Defense, health foundations and state governments.

Simon Lorne
Mr. Lorne has been a Director and member of the Company's Business Advisory Board since October 1999. In 2001, Mr. Lorne agreed to chair the Company's Board of Directors. Mr. Lorne is a Partner in the law firm Munger, Tolles & Olson, LLP. From 1996 to 1999, Mr. Lorne was Managing Director with Salomon Brothers, Inc., and its successor firm Salomon Smith Barney, Inc. From 1993 to 1996, Mr. Lorne was General Counsel of the United States Securities and Exchange Commission. Mr. Lorne received his Juris Doctorate degree from the University of Michigan and his undergraduate degree from Occidental College. Mr. Lorne is also currently co-director of the Stanford Law School's Directors' College.

Johnson Liu
Mr. Liu has served on the Board of Directors since October 1999. Mr. Liu has served as Chairman of BevGlen Medical Systems Corporation since 1999, a healthcare technology company specializing in heart rate variability study and QT prolongative tests for pharmaceutical companies. In 1987, Mr. Liu founded Solidex Medical Systems, LLC, a cardiac monitoring healthcare service company, which was acquired by BevGlen Medical Systems Corporation in 1998. Between 1984 and 1995, Mr. Liu founded and has been Chairman and CEO of Solidex, Inc., an international manufacturer of video, computer and cellular telecommunication equipment. Mr. Liu received his MBA from California State University, Los Angeles and his bachelor's degree from the Fu Jen Catholic University, Taiwan.

Zengen, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing innovative products to treat and prevent infection and inflammation through application of its patented peptide technologies. These technologies are based on an extensive background of over 25 years of academic research on peptide molecules derived from a-Melanocyte-Stimulating Hormone (a-MSH), an endogenous molecule that modulates inflammatory and immune responses.

Zengen Forward Looking Statement Disclaimer:

This announcement may contain, in addition to historical information, certain forward-looking statements that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from those currently anticipated as a result of a number of factors. The company is developing several products for potential future marketing. There can be no assurance that such development efforts will succeed, that such products will receive required regulatory clearance or that, even if such regulatory clearance were received, such products would ultimately achieve commercial success.



To: DanZ who wrote (4732)10/21/2003 10:23:30 AM
From: StockDung  Respond to of 5582
 
GUNNALLEN HIRES RAFFAELE GAMBARDELLA BOILER ROOM INVESTORS ASSOCIATES AND SCHNEIDER SECURITIES GRAD
==================================================

NASD Registered Person: RAFFAELE GAMBARDELLA
CRD Number: 2448073


Employment History

Current Employments: 1
Registrations: 20
Previous Employments: 5


************************************************************
Disclosure Events: Yes
***********************************************************

Criminal Actions: 0
Regulatory Actions: 3
Civil Judicial Actions: 0
Terminations: 0
Customer Complaints: 0
Investigations: 0
Bonds: 0
Bankruptcies: 0
Judgment/Liens: 0


NASD Public Disclosure Program October 21, 2003 Page 2
This information is current as of: 10/21/2003
CURRENT EMPLOYMENT
********************************************************************************




Employing Firm: GUNNALLEN FINANCIAL, INC

Firm CRD Number: 17609
Office of Employment address: 67 WALL STREET
#2005
NEW YORK, NY 10005
USA
Start Date: 09/27/2002 End Date: to present

Registrations:

Jurisdiction/SRO Category Status As Of Date

CA Agent Approved 09/27/2002
CT Agent Approved 09/27/2002
FL Agent Approved 10/23/2002
IL Agent Approved 11/08/2002
MA Agent Approved 11/21/2002
MD Agent Approved 09/27/2002
MI Agent Approved 09/27/2002
NASD General Securities Approved 09/27/2002
Principal
NASD General Securities Approved 09/27/2002
Representative
NASD Registered Options Approved 09/27/2002
Principal
NC Agent Approved 09/27/2002
NJ Agent Approved 09/27/2002
NY Agent Approved 09/27/2002
OH Agent Approved 09/27/2002
PA Agent Approved 10/01/2002
RI Agent Approved 09/27/2002
TX Agent Approved 10/22/2002
VA Agent Approved 09/27/2002
WA Agent Approved 09/27/2002
WI Agent Approved 09/27/2002


Other Business
SOLE PROPRIETOR OF EXPORT AGENCY.

********************************************************************************
PREVIOUS EMPLOYMENT
********************************************************************************


This section provides 10 years of an individual's employment history. If the
individual is currently registered with NASD, employment history will be
displayed for the previous 10 years. If the individual is not currently
registered with NASD, employment history will be displayed for the 10 years
prior to termination of the registration. The firm's CRD number, the office of
employment address where the broker was employed, and the dates of employment
will be displayed.

If the broker was previously employed with an investment adviser, the investment
adviser's name and CRD number will display. However, additional information is
not available on investment advisers through the Public Disclosure Program as
they are not NASD registered firms.

NASD Public Disclosure Program October 21, 2003 Page 3
This information is current as of: 10/21/2003
________________________________________________________________________________
NASD Registered Person: RAFFAELE GAMBARDELLA
CRD Number: 2448073

PREVIOUS EMPLOYMENT(cont.)


If the broker was previously employed with a firm registered with any
self-regulatory organization other than NASD (e.g., the NYSE), either the
firm's name or "Other Business" will display as the Employing Firm. To obtain
the firm's name when "Other Business" displays as the Employing Firm, please
call the Public Disclosure Call Center Hotline number, 1-800-289-9999.

A Firm CRD Number will not display for employing firms that are not NASD
registered firms. Information on these employing firms is not available through
the Public Disclosure Program.


*************** PREVIOUS EMPLOYMENT (1 of 5) ***************

Employing Firm: SCHNEIDER SECURITIES, INC.

Firm CRD Number:
Office of Employment address: NEW YORK, NY
Start Date: 06/1997 End Date: 09/2002



*************** PREVIOUS EMPLOYMENT (2 of 5) ***************

Employing Firm: INVESTORS ASSOCIATES, INC.

Firm CRD Number:
Office of Employment address: NEW YORK, NY
Start Date: 07/1994 End Date: 06/1997



*************** PREVIOUS EMPLOYMENT (3 of 5) ***************

Employing Firm: THE WELLINGTON GROUP, INC.

Firm CRD Number:
Office of Employment address: NEW YORK, NY
Start Date: 02/1994 End Date: 08/1994



*************** PREVIOUS EMPLOYMENT (4 of 5) ***************

Employing Firm: JAMES W. BULLARD, JR., INCORPORATED

Firm CRD Number:
Office of Employment address: NEW YORK, NY
Start Date: 12/1993 End Date: 02/1994



*************** PREVIOUS EMPLOYMENT (5 of 5) ***************

Employing Firm: ITALCVISINE INC.

Firm CRD Number:
Office of Employment address: BELLMORE, NY
Start Date: 09/1992 End Date: 12/1993
































NASD Public Disclosure Program October 21, 2003 Page 4
This information is current as of: 10/21/2003
________________________________________________________________________________
NASD Registered Person: RAFFAELE GAMBARDELLA
CRD Number: 2448073

********************************************************************************
REGULATORY ACTIONS
********************************************************************************
DISCLOSURE INFORMATION


This section lists regulatory actions that were reported to the CRD and are
disclosable through the Public Disclosure Program. Disclosable regulatory
actions include formal proceedings initiated by a regulatory authority (i.e., a
state securities agency, the NASD, New York Stock Exchange, foreign regulatory
body, etc.) for a violation of investment-related rules or regulations. In
addition, revocations or suspensions of a broker's authority to act as an
attorney, accountant or federal contractor will appear here.

Some of the fields in this section of the report may be blank if the information
was not provided to CRD.


** OCCURRENCE COUNTS ** 3 Record(s)

********************************************************************************

** FIELD DEFINITIONS **

* Reporting Source: The form through which details of the regulatory
action was reported to CRD.

* Date Reported: The date the regulatory action was reported to CRD.

* Initiated By: The name of the securities regulator that initiated
the regulatory action (e.g., regulator, foreign
financial regulatory authority, self-regulatory
organization, federal agency such as SEC, state,
etc.).

* Date Initiated: Date the regulatory action was initiated.

* Docket/Case Number: Docket or case number of the regulatory action.

* Employing Firm: Firm where broker was employed when activity
occurred that led to the regulatory action.

* Allegations: Allegations made against the broker leading to the
regulatory action.

* Current Status: The current status of the regulatory action (i.e.,
pending, on appeal or final).

* Resolution: The resolution of the regulatory action (e.g.,
acceptance, waiver and consent; decision; decision
and order of offer of settlement; order; settled;
etc.).

* Resolution Date: The date the regulatory action was resolved.

* Sanction Details: Additional details regarding any sanctions ordered.

* Summary: A summary of the details related to the regulatory
action.

********************************************************************************


******** REGULATORY ACTION (1 of 3) ********


Reporting Source: Regulator (Form U-6)

Date Reported: 02/27/2001

Initiated By: NATIONAL ASSOCIATION OF SECURITIES DEALERS, INC.

Date initiated: 09/20/2000

Docket/
Case Number: C3A000032

Employing Firm: SCHNEIDER SECURITIES, INC.

Allegations: 09/29/00EC: NASD RULES 2110 AND 3010 - A MEMBER FIRM, ACTING
THROUGH RESPONDENT GAMBARDELLA, FAILED TO ADEQUATELY SUPERVISE
A FORMER REGISTERED REPRESENTATIVE TO PREVENT AND DETECT
ALLEGED EXCESSIVE TRADING, UNAUTHORIZED TRADING AND THE
IMPROPER USE OF DISCRETION.

Current Status: Final

Resolution: Acceptance, Waiver & Consent(AWC)

Resolution Date: 09/20/2000

Sanctions

NASD Public Disclosure Program October 21, 2003 Page 5
This information is current as of: 10/21/2003
________________________________________________________________________________
NASD Registered Person: RAFFAELE GAMBARDELLA
CRD Number: 2448073

REGULATORY ACTIONS(cont.)

Ordered: Monetary/Fine, Censure

Monetary Amount: $5,000.00

Resolution
Details: A CENSURE AND $5,000.00 FINE. 02-27-01, $5,000 PAID 10/27/00,
INVOICE 00-3A-690

Summary:


***********************************
Reporting Source: Broker (Form U-4)

Date Reported: 11/21/2000

Initiated By: NASD

Date initiated: 12/29/1999

Docket/
Case Number: C3A950022

Employing Firm: SCHNEIDER SECURITIES, INC.

Allegations: THE NASD DIST #3 ALLEGED THAT I FAILED TO SUPERVISE THE
ACTIVITY OF A BROKER WHILE HE WAS ASSOCIATED WITH SCHNEIDER
SECURITIES, INC.

Current Status: Final

Resolution: Acceptance, Waiver & Consent(AWC)

Resolution Date: 09/20/2000

Sanctions
Ordered: Monetary/Fine, Censure

Monetary Amount: $5,000.00

Resolution
Details: THERE WERE NO OTHER REQUIREMENTS AND SANCTIONS THAT WERE PART
OF THE CENSURE. ON 10/25/2000 THE $5000.00 WAS PAID.

Summary:



******** REGULATORY ACTION (2 of 3) ********


Reporting Source: Regulator (Form U-6)

Date Reported: 10/16/1997

Initiated By: WASHINGTON STATE SECURITIES DIVISION

Date initiated: 05/28/1997

Docket/
Case Number: SDO-42-97

Employing Firm: INVESTORS ASSOCIATES, INC.

Allegations: FAILURE TO SUPERVISE

Current Status: Final

Resolution: Vacated

Resolution Date: 10/16/1997

Sanctions
Ordered:

Resolution
Details: SUMMARY SUSPENSION OF REGISTRATION ORDER NO. SDO-42-97 IS
REVOKED AS TO GAMBARDELLA BY SDO-68-97 .

Summary: CONTACT: REX STAPLES (360) 902-8734


***********************************
Reporting Source: Firm (Form U-5)

Date Reported: 06/24/1997

Initiated By: WASHINGTON STATE SECURITIES.

Date initiated: 05/28/1997

NASD Public Disclosure Program October 21, 2003 Page 6
This information is current as of: 10/21/2003
________________________________________________________________________________
NASD Registered Person: RAFFAELE GAMBARDELLA
CRD Number: 2448073

REGULATORY ACTIONS(cont.)


Docket/
Case Number: SDO-42-97

Employing Firm: INVESTORS ASSOCIATES, INC.

Allegations: THIS PROCEEDING SUSPENDING THE APPLICANTS REGISTRATION WAS
INITIATED BASED ON THE STATES OF INDIANA AND NEW HAMPSHIRE
REVOKING APPLICANT'S REGISTRATION.

Current Status: Final

Resolution: Vacated

Resolution Date: 10/16/1997

Sanctions
Ordered:

Resolution
Details: REGISTRATION WAS SUSPENDED WITH INTENT TO REVOKE.

Summary: Not Provided


***********************************
Reporting Source: Broker (Form U-4)

Date Reported: 06/19/1997

Initiated By: STATE OF WASHINGTON

Date initiated: 05/28/1997

Docket/
Case Number: SDO-42-97

Employing Firm: INVESTORS ASSOCIATES, INC.

Allegations: APPLICANT WAS ALLEGED TO BE THE SUPERVISOR OF A REGISTERED
REPRESENTATIVE WHO ENGAGED IN VIOLATIONS.

Current Status: Final

Resolution: Vacated

Resolution Date: 10/16/1997

Sanctions
Ordered:

Resolution
Details: WASHINGTON ISSUED AN AMENDED ORDER VACATING THE PREVIOUS
SUMMARY SUSPENSION ORDER AS TO GAMBARDELLA AND NOT NAMING HIM
IN THE CASE, THEREBY WITHDRAWING THE CASE AS TO HIM.

Summary: Not Provided



******** REGULATORY ACTION (3 of 3) ********


Reporting Source: Regulator (Form U-6)

Date Reported: 11/12/1997

Initiated By: NEW JERSEY BUREAU OF SECURITIES

Date initiated: 05/28/1997

Docket/
Case Number:

Employing Firm: INVESTORS ASSOCIATES, INC.

Allegations: ADMINISTRATIVE COMPLAINT ISSUED PROPOSING TO REVOKE RAFFAELE
GAMBARDELLA AGENT REGISTRATION AT IAI FOR, AMONG OTHER THINGS:
EMPLOYING HIGH PRESSURE BOILER ROOM SALES PRACTICES IN
CONNECTION WITH THE OFFER, SALE OR PURCHASE OF SECURITIES IN
ORDER TO DEFRAUD INVESTORS; AND SELLING UNREGISTERED
SECURITIES IN AND FROM NEW JERSEY. CIVIL MONETARY PENALTIES
REQUESTED IN THE ADMINISTRATIVE COMPLAINT. A CEASE AND DESIST
ORDER WAS SIMULTANEOUSLY ISSUED WITH THE ADMINISTRATIVE
COMPLAINT, WHICH ORDERED RAFFAELE GAMBARDELLA TO IMMEDIATELY
CEASE AND DESIST FROM: OFFERING OR SELLING UNREGISTERED
SECURITIES WITHIN, FROM OR INTO NEW JERSEY; HIRING OR
EMPLOYING, DIRECTLY OR INDIRECTLY, UNREGISTERED AGENTS; AND
DEFRAUDING INVESTORS IN VIOLATION OF NEW JERSEY ANTI-FRAUD
PROVISIONS. THE NJ BUREAU OF SECURITIES MOTION FOR PARTIAL

NASD Public Disclosure Program October 21, 2003 Page 7
This information is current as of: 10/21/2003
________________________________________________________________________________
NASD Registered Person: RAFFAELE GAMBARDELLA
CRD Number: 2448073

REGULATORY ACTIONS(cont.)

SUMMARY DECISION AND ENTRY OF AN ORDER TO REVOKE THE AGENT
REGISTRATION OF RAFFAELE GAMBARDELLA WHILE EMPLOYED AT
INVESTORS ASSOCIATES, INC. WAS DENIED BY ORDER DATED NOVEMBER
12, 1997. GAMBARDELLAS CROSS MOTICE FOR SUMMARY DECISION AND
ENTRY OF AN ORDER WAS GRANTED. COMPLAINT AND CEASE AND DESIST
ORDER DATED MAY 28, 1997 DISMISSED AND VACATED.

Current Status: Final

Resolution: Vacated

Resolution Date: 11/24/1997

Sanctions
Ordered:

Resolution
Details: Not Provided

Summary: CONTACT: JOE ALLESSIE AT 973-504-3600


***********************************
Reporting Source: Firm (Form U-5)

Date Reported: 06/24/1997

Initiated By: STATE OF NEW JERSEY BUREAU OF SECURITIES.

Date initiated: 05/28/1997

Docket/
Case Number:

Employing Firm: INVESTORS ASSOCIATES, INC.

Allegations: STATE OF NEW JERSEY BUREAU OF SECURITIES FILED A CEASE AND
DESIST ORDER AGAINST UNLAWFUL ACTS AS SET FORTH IN NJSA
49:3-60, 49:3-50 AND 49:3-52.

Current Status: Final

Resolution: Vacated

Resolution Date: 11/24/1997

Sanctions
Ordered:

Resolution
Details: PENDING.

Summary: Not Provided


***********************************
Reporting Source: Broker (Form U-4)

Date Reported: 10/20/2003

Initiated By: NEW JERSEY BUREAU OF SECURITIES

Date initiated: 05/28/1997

Docket/
Case Number:

Employing Firm: INVESTORS ASSOCIATES, INC.

Allegations: UNLAWFUL ACTS INVOLVING UNREGISTERED SECURITIES, UNREGISTERED
AGENTS, ANTIFRAUD VIOLATIONS.

Current Status: Final

Resolution: Vacated

Resolution Date: 11/24/1997

Sanctions
Ordered:

Resolution
Details: BY ORDER ISSUED 11/24/97, NEW JERSEY DISMISSED THE PROCEEDING
AGAINST APPLICANT GAMBARDELLA AND VACATED THE CEASE AND DESIST
ORDER AS TO HIM.

Summary:


************ END OF REPORT ************

NASD Public Disclosure Program October 21, 2003 Page 8
This information is current as of: 10/21/2003
________________________________________________________________________________
NASD Registered Person: RAFFAELE GAMBARDELLA
CRD Number: 2448073



To: DanZ who wrote (4732)11/9/2003 7:14:39 PM
From: StockDung  Read Replies (1) | Respond to of 5582
 
ATTENTION FAKE PDH/MBA DAVIDSON FANS-THE ROLE OF SPECIFIC OLFACTORY STIMULATION IN APPETITE SUPPRESSION AND WEIGHT LOSS
  

Dr. S.N. Mayer, Dr. R.S. Davidson and Dr. C.B. Hensley
mediaalertnewsbureau.com